Male involvement in randomised trials testing psychotherapy or behavioural interventions for depression: a scoping review.
Curr Psychol
; : 1-16, 2022 Dec 05.
Article
em En
| MEDLINE
| ID: mdl-36531196
ABSTRACT
The prevalence of Major Depressive Disorder in men is half that of women, yet depression affects approximately 109 million men worldwide. Alarmingly, men account for three quarters of suicides in Western countries but are unlikely to seek help for mental health concerns. It is possible that existing mental health treatments are not engaging or accessible to men. The aim of this review was to quantify the number of men involved in randomised trials of psychotherapy or lifestyle behaviour change targeting depression. Results found men represented 26% of participants in 110 eligible articles compared to 73% women. Men's representation was low across all intervention characteristics (e.g., delivery mode). No studies used a completely male sample, compared to 19 studies targeting women only. Men are substantially underrepresented in research trials targeting depression. Supplementary information The online version contains supplementary material available at 10.1007/s12144-022-04017-7.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Risk_factors_studies
/
Systematic_reviews
Idioma:
En
Revista:
Curr Psychol
Ano de publicação:
2022
Tipo de documento:
Article